Effect of NK Cell Immunotherapy on Advanced Lung Adenocarcinoma Adenocarcinoma With EGFR Mutation
Clinical trial NCT03662477 · UNKNOWN
Trial details
- NCT number
- NCT03662477
- Sponsor
- Shenzhen Fifth People's Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-01
- Primary completion
- 2019-12-20
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.